Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Consolidated Statements of Shareholders' Deficit

v3.21.1
Consolidated Statements of Shareholders' Deficit - USD ($)
Share Capital [member]
Contributed Surplus [member]
Deficit [member]
Total
Beginning balance at Dec. 31, 2018 $ 170,502,394 $ 6,652,409 $ (172,937,694) $ 4,217,109
Beginning balance, share at Dec. 31, 2018 21,675,849      
Statement Line Items [Line Items]        
Issued pursuant to agency agreement $ 13,717,131 13,717,131
Issued pursuant to agency agreement, shares 8,455,882      
Issued pursuant to private placements $ 5,727,971 5,727,971
Issued pursuant to private placements, shares 8,757,444      
Share issue expense $ (2,090,124) (2,090,124)
Warrants exercised during the year $ 7,002,043 7,002,043
Warrants exercised during the year, shares 1,018,506      
Stock based compensation 1,651,118 1,651,118
Net and Comprehensive loss     (41,907,079) (41,907,079)
Ending balance at Dec. 31, 2019 $ 194,859,415 8,303,527 (214,844,773) $ (11,681,831)
Ending balance, shares at Dec. 31, 2019 39,907,681     39,907,681
Statement Line Items [Line Items]        
Issued pursuant to agency agreement [1] $ 12,818,657 $ 12,818,657
Issued pursuant to agency agreement, shares [1] 23,923,700      
Share issue expense $ (487,788) (487,788)
Common stock equivalents converted $ 1,150 1,150
Common stock equivalents converted, shares 11,500,000      
Warrants exercised during the year $ 8,627,619 8,627,619
Warrants exercised during the year, shares 7,853,462      
Stock based compensation 1,097,358 1,097,358
Net and Comprehensive loss (24,184,657) (24,184,657)
Ending balance at Dec. 31, 2020 $ 215,819,053 $ 9,400,885 $ (239,029,430) $ (13,809,492)
Ending balance, shares at Dec. 31, 2020 83,184,843     83,184,843
[1] Includes net proceeds from the issuance of common share equivalents (see note 9 a)